Table 1. Demographic characteristics at COVID-19 diagnosis.
| Non-missing cases | Total N = 1,680 | |
|---|---|---|
| Age (years) | 1,680 | 51.3 (41.7–60.0) |
| Age group | 1,680 | |
| < 18 years | 14 (0.8) | |
| 18–60 years | 1261 (75.1) | |
| > 60 years | 405 (24.1) | |
| Male sex | 1,680 | 1,015 (60.4) |
| Afro-Brazilian ethnicity | 1,680 | 191 (11.4) |
| BMI (kg/m2) | 1,588 | 26.5 (23.6–29.7) |
| BMI ≥ 30 kg/m2 | 1,588 | 378 (23.8) |
| Donor source | 1,680 | |
| KT-LD | 524 (31.2) | |
| KT-DD | 1,120 (66.7) | |
| SPK | 23 (1.4) | |
| PAK | 1 (0.1) | |
| SLK | 7 (0.4) | |
| KAL | 4 (0.2) | |
| SHK | 1 (0.1) | |
| Time after KT (years) | 1,676 | 5.9 (2.3–10.7) |
| KT ≤ 30 days | 1,676 | 41 (2.4) |
| Comorbidities | 1,680 | |
| None | 191 (11.4) | |
| Hypertension | 1,272 (75.7) | |
| Diabetes | 571 (34.0) | |
| Cardiovascular | 206 (12.3) | |
| Pulmonary | 54 (3.2) | |
| Neurologic | 20 (1.2) | |
| Hepatic | 63 (3.8) | |
| Neoplasia | 84 (5.0) | |
| Autoimmune | 49 (2.9) | |
| IS regimen | 1,680 | |
| CNI-AZA | 261 (15.5) | |
| CNI-MPA | 998 (59.4) | |
| CNI-mTORi | 157 (9.3) | |
| CNI-free | 165 (9.8) | |
| Other | 99 (5.9) | |
| eGFR (mL/min/1.73 m2) | 1,497 | 48.4 (32.4–65.4) |
AZA, azathioprine; BMI, body mass index; CNI, calcineurin inhibitor; DD, deceased donor; eGFR, estimated glomerular filtration rate; IS, immunosuppressive; KAL, kidney after liver; KT, kidney transplant; LD, living donor; mTORi, mammalian target of rapamycin inhibitor; PAK, pancreas after kidney; SHK, simultaneous heart-kidney; SLK, simultaneous liver-kidney; SPK, simultaneous pancreas-kidney.